Barinskiĭ I F, Davydova A A, Gribencha S V, Lazarenko A A
Vopr Virusol. 1996 May-Jun;41(3):133-5.
Antiviral activity of rybamidil (virasol) and interferon inducers ridostine and camedone developed in Russia and introduced in practical medicine has been studied in mice with experimentally induced arboviral infections, flavivirus (tick-borne encephalitis-TBE, and yellow fever-YF) and alphavirus ones (Western and Eastern equine encephalomyelitis-WEE and EEE). Rybamidil injected subcutaneously proved to be ineffective both for prevention and treatment of these infections. Early interferon inducers ridostine and camedone (larifan) with a peak of interferon production 4 hours after injection, when used in doses of 5 and 150 mg/ kg, respectively, had a clear-cut prophylactic antiviral effect if injected 24 or 4 hours before infection. Ridostine had a distinct antiviral effect, providing up to 40% protection from TBE, YF, and WEE.
在俄罗斯研制并应用于临床医学的瑞巴米迪(病毒唑)、干扰素诱导剂利多嘧啶和卡米酮,对实验性感染虫媒病毒(黄病毒属——蜱传脑炎病毒和黄热病毒,甲病毒属——西方马脑炎病毒和东方马脑炎病毒)的小鼠的抗病毒活性进行了研究。皮下注射瑞巴米迪对这些感染的预防和治疗均无效。早期干扰素诱导剂利多嘧啶和卡米酮(拉立凡)在注射后4小时达到干扰素产生高峰,分别以5毫克/千克和150毫克/千克的剂量使用时,若在感染前24小时或4小时注射,具有明确的预防性抗病毒作用。利多嘧啶具有显著的抗病毒作用,对蜱传脑炎病毒、黄热病毒和西方马脑炎病毒提供高达40%的保护。